IMFINZI® (non-proprietary name: Durvalumab) is a PD-L1 blocking antibody1, and is available in 500mg and 120mg1 dosages. Provided by the UK's pharmaceutical company, AstraZeneca (HK). IMFINZI® is a Hong Kong Department of Health prescription drug. For enquiry, please contact your doctor or pharmacist.


  1. Imfinzi Hong Kong Prescribing Information. Jun 2021.